Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | 5 | 2 | — | — | — | 5 |
Drug common name | CEVOSTAMAB |
INN | cevostamab |
Description | Cevostamab is an antibody pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4297908 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | P86BHN01VE (ChemIDplus, GSRS) |